HIPEC improves survival in stage III epithelial ovarian cancer

被引：4
|
作者：
Stirrups, Robert
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(18)30065-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E138 / E138
页数：1
相关论文
共 50 条
  • [31] Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
    Mackay, Helen J.
    Brady, Mark F.
    Oza, Amit M.
    Reuss, Alexander
    Pujade-Lauraine, Eric
    Swart, Ann M.
    Siddiqui, Nadeem
    Colombo, Nicoletta
    Bookman, Michael A.
    Pfisterer, Jacobus
    du Bois, Andreas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (06) : 945 - 952
  • [32] Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation study
    Tate, Shinichi
    Kato, Kazuyoshi
    Nishikimi, Kyoko
    Matsuoka, Ayumu
    Shozu, Makio
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 73 - 80
  • [33] Smoking and overweight:: Negative prognostic factors in stage III epithelial ovarian cancer
    Kjærbye-Thygesen, A
    Frederiksen, K
    Hogdall, EV
    Glud, E
    Christensen, L
    Hogdall, CK
    Blaakaer, J
    Kjær, SK
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (04) : 798 - 803
  • [34] Comparison of Primary Tumor Size in Stage I and III Epithelial Ovarian Cancer
    Petru, Edgar
    Huber, Carola
    Sampl, Eva
    Haas, Josef
    ANTICANCER RESEARCH, 2018, 38 (11) : 6507 - 6511
  • [35] Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial
    Koole, Simone
    van Stein, Ruby
    Sikorska, Karolina
    Barton, Desmond
    Perrin, Lewis
    Brennan, Donal
    Zivanovic, Oliver
    Mosgaard, Berit Jul
    Fagotti, Anna
    Colombo, Pierre-Emmanuel
    Sonke, Gabe
    van Driel, W. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 888 - 892
  • [36] Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancer
    Balbi, GC
    Menditto, A
    Calabria, G
    Musone, R
    Di Prisco, L
    Cassese, E
    Balbi, C
    Cardone, A
    PANMINERVA MEDICA, 2001, 43 (04) : 263 - 265
  • [37] Adjuvant chemotherapy improves survival after resection of stage 1 ovarian cancer
    Kitchener, HC
    CANCER TREATMENT REVIEWS, 2005, 31 (04) : 323 - 327
  • [38] HIPEC is associated with improved survival in stage III-IV ovarian cancer patients undergoing complete cytoreductive surgery: An NCDB-based analysis
    Kohut, Adrian
    Santiago, Nicole Lugo
    Attiyeh, Marc
    Malhotra, Gautam
    Tran, Thuy
    Cloud, Talie
    Lee, Stephen
    Dellinger, Thanh
    Tergas, Ana
    Hakim, Amy
    Kebria, Mehdi
    de Leon, Maria
    Lin, Wei-Chien
    Wang, Edward
    Stewart, Daphne
    Cristea, Mihaela
    Han, Ernest
    Song, Mihae
    Rodriguez-Rodriguez, Lorna
    Raoof, Mustafa
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S273 - S274
  • [39] Clinicopathological parameters and survival of invasive epithelial ovarian cancer by histotype and disease stage
    Lan, Aihua
    Yang, Gong
    FUTURE ONCOLOGY, 2019, 15 (17) : 2029 - 2039
  • [40] Epithelial ovarian cancer: Response to treatment and survival in patients with stage IV at diagnosis
    Mendez, SG
    Arija, JAA
    Arenas, CG
    Criado, PL
    Beca, RG
    Martinez, JMM
    de Juan, CL
    Torralba, CC
    Plaza, IP
    Manga, GP
    ANNALS OF ONCOLOGY, 1998, 9 : 72 - 72
12345